Last reviewed · How we verify
Maintenance of the current regimen — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Maintenance of the current regimen (Maintenance of the current regimen) — Hospital do Rim e Hipertensão. Continuation of an existing therapeutic regimen without modification to maintain current clinical stability and treatment efficacy.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Maintenance of the current regimen TARGET | Maintenance of the current regimen | Hospital do Rim e Hipertensão | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Maintenance of the current regimen CI watch — RSS
- Maintenance of the current regimen CI watch — Atom
- Maintenance of the current regimen CI watch — JSON
- Maintenance of the current regimen alone — RSS
Cite this brief
Drug Landscape (2026). Maintenance of the current regimen — Competitive Intelligence Brief. https://druglandscape.com/ci/maintenance-of-the-current-regimen. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab